NCT06257212View on ClinicalTrials.gov

Live Vaccines and Innate Immune Training in COPD.

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Trained Innate ImmunityCOPD
Interventions
DRUG

BCG vaccine (Danish strain 1331)

Intradermal BCG vaccine (0.1 ml) + subcutaneous saline at inclusion and after 3 months.

DRUG

MMR Vaccine

Subcutaneous MMR vaccine (0.5ml) + intradermal saline at inclusion and after 3 months.

DRUG

Placebo

Subcutaneous saline + intradermal saline at inclusion and after 3 months.

Trial Locations (1)

2900

RECRUITING

Department of Internal Medicine, Section of Respiratory Medicine, Hellerup

All Listed Sponsors
lead

Josefin Eklöf

OTHER